Two presentations, including one oral session, build on existing data and show deep and durable clinical remission rates, combined with a strong safety profile, for SENTI-202 in treating ...
AGOURA HILLS, Calif.--(BUSINESS WIRE)--A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies for solid tumors, today announced ...
Bio-logic Systems Corp. is selling 14 acres of vacant land next to its Mundelein headquarters for a sum worth 10% of last year's revenues, the company said Monday in a regulatory filing. Buying the ...
The ability for cells to control gene expression in response to changing conditions is crucial for their survival. People spend their entire careers teasing apart these mechanisms, many of which are ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--LogicBio Therapeutics, Inc., a gene-therapy company with a mission to develop transformative medicines for life-threatening diseases, today announced the expansion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results